Abstract
More than a decade after the identification of human immunodeficiency virus-1 (HIV-1) as the causative pathogen of AIDS, the prospects for an HIV-1 vaccine in the foreseeable future are still low. Attempts using conventional vaccine approaches have not met with much success (for recent reviews see Haynes 1993; Bolognesi 1993, 1995). The live attenuated vaccine approach appeared promising when its effectiveness was demonstrated in a simian immunodeficiency virus (SIV) model in macaques (Daniel et al. 1994, 1992). However, additional studies in neonatal macaques raised safety concerns regarding this approach (Baba et al. 1995). The search for novel vaccine strategies that target the unique biological features of HIV-1 remains a challenging yet important task.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson KP, Lucas C, Hanson CV, Londe HF, Izu A, Gregory T, Ammann A, Berman PW, Eichberg JW (1989) Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1. J Inf Dis 160:960–969
Almond N, Kent K, Cranage M, Rud E, Clarke B, Stott EJ (1995) Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342–1344
Baba TW, Jeong YS, Penninck D, Bronson R, Greene MF, Ruprech RM (1995) Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820–1825
Bolognesi DP (1993) Human immunodeficiency virus vaccines. Adv Virus Res 42:103–148
Bolognesi DP (1995) Ch. 20: The dilemma of developing and testing AIDS vaccines. In: Copper GM, Temin RG, and Sugden B (eds) The DNA provirus: Howard Temin’s scientific legacy. American Society for Microbiology, Washington, DC, pp 301–312
Burns DPW, Desrosiers RC (1992) A caution on the use of SIV/HIV gag antigen detection system in neutralization assays. AIDS Res Hum Retroviruses 8:1189–1192
Cox GJM, Zamb TJ, Babiuk LA (1993) Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol 67:5664–5667
Davis HL, Michel M-L, Whalen RG (1993) DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Human Mol Gen 2:1847–1851
Daniel MD, Kirchhoff F, Czajak SC, Simon MA, Sehgal PK, Desrosiers RC (1992) Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938–1941
Daniel MD, Mazzara GP, Simon MA, Sehgal PK, Kodama T, Panicali DL, Desrosiers RC (1994) Hightiter immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Res Hum Retroviruses 10:839–851
Dresser DW (1986) Immunization of experimental animals. In Weir DM (ed.): Immunochemistry, Handbook of Experimental Immunology, Blackwell Scientific Publications, Oxford, 1:8.1–8.21.
Fuller DH, Haynes JR (1994) A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res Hum Retroviruses 10:1433–1441
Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL (1993) DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations Proc Natl Acad Sci USA 90:11478–11482
Giard M, Kieny M-P, Pinter A, Barre-Sinoussi F, Nara P, Kolbe H, Kusumi K, Chaput A, Reinhart T, Muchmore E, Ronco J, Kaczorek M, Gomard E, Gluckman J-C, Fultz PN (1991) Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci USA 88:542–546
Graham BS, Gorse GJ, Schwartz DH, Keefer MC, McElrath MJ, Matthews TJ, Wright PF, Belshe RB, Clements ML, Dolin R, Corey L, Bolognesi DP, Sin DM, Esterlitz JR, Hu S-L, Smith GE and NIAID AIDS vaccine clinical trials network. (1994) Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. J Infect Dis 170:782–786
Haigwood NL, Nara PL, Brooks E, Van Nest GA, Ott G, Higgins KW, Dunlop N, Scandella CJ, Eichberg JW, Steimer KS (1992) Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. J Virol 66:172–182
Haynes BF (1993) Scientific and social issues of human immunodeficiency virus vaccine development. Science 260:1279–1286
Heath SL, Tew JG, Tew JG Szakal AK, Burton GF (1995) Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377:740–744
Herrmann JE, Chen SC, Fynan EF, Santoro JC, Greenberg HB, Robinson HL (1996) DNA vaccines against rotavirus infections. Arch Virol (in press)
Hirsh VM, Johnson PR (1994) Pathogenic diversity of siman immunodeficiency viruses. Virus Research 32:183–203
Hu S-L, Stallard V, Abrams K, Barber GN, Kuller L, Langlois AJ, Morton WR, Benveniste RE (1993) Protection of vaccinia-primed macaques against SIVmac infection by combination immunization with recombinant vaccinia virus and SIVmne gp160. J Med Primatol 22:92–99
Javaherian K, Langlois AJ, Montefiori DC, Kent KA, Ryan KA, Wyman PD, Stott J, Bolognesi DP, Murphey-Corb M, LaRosa GJ (1994) Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. J Virol 68:2624–2631
Koup RA, Safrit JT, Cao Y, Andrews CA, Wu Y, McLeod G, Borkowsky W, Farthing C, Ho DD (1994) Temporal association of cellular immune response with the initial control of viremia in primary HIV-1 syndrome. J Virol 68:4650–4655
Li J, Haseltine W, Letvin NL, Sodroski J (1992) Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that express the HIV-1 envelope glycoprotein. J AIDS 5:639–664
Letvin NL (1993) Vaccines against the human immunodeficiency viruses: progress and prospects. N Engl J Med 329:1400–1405
Lu S, Santoro JC, Fuller DH, Haynes JR, Robinson HL (1995) Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 209:147–154
Lu S, Arthos J, Montefiori DC, Yasutomi Y, Manson K, Mustafa F, Johnson E, Santoro JC, Wissink J, Mullins JI, Haynes JR, Letvin NL, Wyand M, Robinson HL (1996) Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol 70:3978–3991
Martins LP, Lau LI, Asano MS Ahmed R (1995) DNA vaccination against persistent viral infection. J Virol 69:2574–2582
Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM, and the National Institutes of Health AIDS Vaccine Clinical Trials Network (1994) Binding of human immunodeficiency virus 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. J Infect Dis 170:429–32
Mor G, Klinman DM, Shapiro S, Hagiwara E, Sedegah M, Norman JA, Hoffman SL, Steinberg AD (1995) Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J Immunol 155:2039–2046
Putkonen P, Thorstensson R, Walther L, Albert J, Akerblom L, Granquist O, Wadell G, Norrby E, Biberfeld G (1991) Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Res Hum Retroviruses 7:271–277
Putkonen P, Nilsson C, Walther L, Ghavamzadeh L, Hild K, Broliden K, Biberfeld G, Thorstensson R (1994) Efficacy of inactivated whole HIV-2 vaccines with various adjuvants in cynomolgus monkeys. J Med Primatol 23:89–94
Robinson HL, Feltquate DM, Morin MJ, Haynes JR, Webster RG (1995) DNA vaccines: a new approach to immunization. In: Chanock RM, Brown F, Ginsberg HS and Norrby E (eds) Vaccines 95. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 69–75
Sakuragi S, Shibata R, Mukai R, Komatsu T, Fukasawa M, Sakai H, Saduragi J-I, Kawamura M, Ibuki K, Hayami M, Adachi A (1992) Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus. J Gen Virol 73:2983–2987
Shafferman A, Jahrling PB, Benveniste RE, Lewis MG, Phipps TJ, Eden-McCutchan F, Sadoff J, Eddy GA, Burke DS (1991) Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc Natl Acad Sci USA 88:7126–7130
Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgonery DL, Liu MA (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745–1749
Wang B, Ugen KE, Srikantan V, Agadmanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB (1993a) Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90:4156–4160
Wang B, Boyer J, Srikantan V, Coney L, Carrano R, Phan C, Merva M, Dang K, Agadmanyan MG, Gilbert L, Ugen KE, Williams WV, Weiner DB (1993b) DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA and Cell Biology 12:799–805
Wang B, Merva M, Dang K, Ugen KE, Williams WV, Weiner DB (1995a) Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Human Gene Therapy 6:407–418
Wang B, Boyer JD, Ugen KE, Srikantan V, Ayyaroo V, Agadmanyan MG, Williams WV, Newman M, Coney L, Carrano R, Weiner DB (1995b) Nucleic acid-based immunization against HIV-1: induction of protective in vivo immune responses. AIDS 9(suppl A):S159–S170
Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, Desrosiers RC (1996) Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 70:3724–3733
Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HCJ (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132–140
Yasutomi Y, Reimann KA, Lord CI, Miller MD, Letvin NL (1993) Simian immunodeficiency virus- specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol 67:1707–1711
Yasutomi Y, Robinson HL, Lu S, Mustafa F, Lekutis C, Arthos J, Mullins J, Voss G, Manson K, Wyand M, Letvin NL (1996) Simian immunodeficiency virus-specific cytotoxic T lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol 70:678–681
Zarozinski CC, Fynan EF, Selin LK, Robinson HL, Welsh RM (1995) Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J Immunol 154:4010–4017
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lu, S. (1998). Developing DNA Vaccines Against Immunodeficiency Viruses. In: Koprowski, H., Weiner, D.B. (eds) DNA Vaccination/Genetic Vaccination. Current Topics in Microbiology and Immunology, vol 226. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80475-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-80475-5_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80477-9
Online ISBN: 978-3-642-80475-5
eBook Packages: Springer Book Archive